Status: current, Defined. Date: 31-Jul 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4830791000168115 | Xeljanz XR (tofacitinib 11 mg) modified release tablet, 28 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4830801000168119 | Xeljanz XR 11 mg modified release tablet, 28, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Xeljanz XR 11 mg modified release tablet, 28, blister pack | Is a | Xeljanz XR 11 mg modified release tablet, 28 | true | Inferred relationship | Some | ||
| Xeljanz XR 11 mg modified release tablet, 28, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Xeljanz XR 11 mg modified release tablet, 28, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Xeljanz XR 11 mg modified release tablet, 28, blister pack | has TP | Xeljanz XR | true | Inferred relationship | Some | ||
| Xeljanz XR 11 mg modified release tablet, 28, blister pack | has TPUU | Xeljanz XR 11 mg modified release tablet | true | Inferred relationship | Some | 110913616 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Black Triangle Scheme reference set
Containered trade product pack reference set
FHIR